Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Molecular Diagnostics » Microbiotica, Cambridge Researchers to Study Microbiome Impact on Immunotherapy Response

Microbiotica, Cambridge Researchers to Study Microbiome Impact on Immunotherapy Response

Jun 08, 2020
|
staff reporter

NEW YORK – Cambridge, UK-based Microbiotica today announced that it will collaborate with Cancer Research UK and Cambridge University Hospitals NHS Foundation Trust (CUH) to develop microbiome co-therapeutics for cancer patients and identify gut bacteria signatures capable of predicting patients' response or resistance to immune checkpoint inhibitors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Oct
08
Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Sponsored by
Genecentric

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct
14
Featured Webinar

Application of ctDNA Analysis to Detect MRD and Predict Recurrence in Colorectal Cancer

Sponsored by
Inivata

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.

Oct
15
Featured Webinar

A Comparison of cfDNA Approaches to Guide Targeted Therapy in NSCLC

Sponsored by
Agena Bioscience

In non-small cell lung cancer (NSCLC), early detection of emerging resistance mutations such as EGFR T790M is important in order to determine the appropriate targeted therapeutic strategy.

Oct
20
Featured Webinar

Crystal Digital PCR for Accurate Chimerism Monitoring after Stem Cell Transplantation

Sponsored by
Stilla

This webinar will discuss a new method that relies on Crystal digital PCR from Stilla Technologies to monitor chimerism in patients after stem cell transplantation, which is a key part of surveillance for impending clinical relapse.

What's Popular?

In Cancer

  1. Sema4, Janssen Partner on Patient Identification for Cancer Clinical Trials

  2. Algorithm Uncovers New Complex Rearrangement Classes in Cancer Genomes

  3. Oncocyte, Chronix Enter Licensing, Collaboration Agreement for Liquid Biopsy Technology

  4. Biocartis Receives €1.2M Flemish Government Grant to Develop GeneFusion Assay on Idylla Platform

  5. Agendia Adds to Data Supporting Breast Cancer Assay in Guiding Long-Term Endocrine Therapy Use

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.